Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia
Phase 2
Recruiting
- Conditions
- Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML)
- Interventions
- Drug: QHRD107 capsule，Venclexta and Azacitidine
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Changzhou Qianhong Bio-pharma Co., Ltd.
- Target Recruit Count
- 53
- Registration Number
- NCT06532058
- Locations
- 🇨🇳
Henan Cancer Hospital, Zhengzhou, Henan, China
🇨🇳The First People's Hospital of Changzhou, Changzhou, Jiangsu, China
🇨🇳Huai 'an First People's Hospital, Huaian, Jiangsu, China
Study to Assess PK, Safety and Tolerability Early in Healthy Subjects
Phase 1
Completed
- Conditions
- Acute Ischemic Stroke
- Interventions
- Drug: QHRD106 InjectionDrug: placebo
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- Changzhou Qianhong Bio-pharma Co., Ltd.
- Target Recruit Count
- 74
- Registration Number
- NCT06388772
- Locations
- 🇨🇳
Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China
Study to Assess PK, Safety and Tolerability in Healthy Subjects
Phase 1
Completed
- Conditions
- Acute Ischemic Stroke
- Interventions
- First Posted Date
- 2024-04-24
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- Changzhou Qianhong Bio-pharma Co., Ltd.
- Target Recruit Count
- 56
- Registration Number
- NCT06380699
- Locations
- 🇨🇳
Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China
News
No news found